Author, year | Mean age (y) | n-3 dosage (EPA/DHA) | Control/placebo | Duration | Sample size ( n) | Method of administration |
---|---|---|---|---|---|---|
Rondanelli et al. 2010 [40] | 84.9 | 1.67Â g/d EPA; 0.83Â g/d DHA | Paraffin oil | 8Â weeks | 46 | Liquid |
a Bechoua et al. 2003 [29] | 75.6 | 30Â mg/d EPA 150Â mg/d DHA | Sunflower oil | 6Â weeks | 20 | Capsules |
b Vericel et al. 1999 [30] | Â | Â | Â | Â | Â | Â |
Gruenwald et al. 2009 [42] | 62.3 | 0.6Â g/d EPA/DHA | Glucosamine sulfate | 26Â weeks | 177 | Capsules |
a Van de Rest et al. 2009 [36] | 69.8 | 1.8Â g/d EPA/DHA (high-dose); OR 0.4Â g/d EPA/DHA (low dose) | High-oleic sunflower oil | 26Â weeks | 302 | Capsules |
b Bouwens et al. 2009 [39] | Â | Â | Â | Â | Â | Â |
c Van de Rest et al. 2008 [37] | Â | Â | Â | Â | Â | Â |
d Van de Rest et al. 2008 [38] | Â | Â | Â | Â | Â | Â |
Querques et al. 2009 [41] | 72.7 | 0.72Â g/d EPA; 0.48Â g/d DHA | Usual care | 26Â weeks | 38 | Unclear |
a Thies et al. 2001 [31] | 55-75 | 0.7 g/d DHA; OR 0.72 g/d EPA; 0.28 g/d DHA | α-linolenic acid, γ-linolenic acid, OR arachidonic acid | 12 weeks | 46 | Capsules |
b Thies et al. 2001 [32] | Â | Â | Â | Â | Â | Â |
a Vedin et al. 2010 [33] | 74 | 0.6Â g/d EPA; 1.72Â g/d DHA | Corn oil | 52Â weeks | 174 | Capsules |
b Vedin et al. 2008 [34] | Â | Â | Â | Â | Â | Â |
c Freund-Levi et al. 2006 [35] | Â | Â | Â | Â | Â | Â |
Smith et al. 2011 [45] | 71 | 1.86Â g/d EPA; 1.5Â g/d DHA | Corn oil | 8Â weeks | 15 | Capsules |
Fakhrzadeh et al. 2010 [43] | 74.8 | 180Â mg/d EPA; 120Â mg/d DHA | Â | 26Â weeks | 124 | Capsules |
Holguin et al. 2005 [44] | 76.5 | 2Â g/d total marine triglycerides; each 1Â g containing 83.2% EPA/DHA | Soy oil | 26Â weeks | 52 | Capsules |